Диссертация (1139658), страница 41
Текст из файла (страница 41)
– [Accessdate: 18.05.2018].316.Latorre, I. Dormancy antigens as biomarkers of latent tuberculosis infection/ I. Latorre, J. Domínguez // EBioMedicine. – 2015. – Vol. 2, № 8. – P. 790-791.317.Levinson, W. Medical Microbiology & Immunology: Examination &Board Review / W. Levinson. – The McGraw-Hill Companies, Inc, 2004. – 644p.318.Liles, W. C. Review: nomenclature and biologic significance of cytokinesinvolved in inflammation and the host immune response / W. C.
Liles, W. C. VanVoorhis // J. Infect. Dis. – 1995. – Vol. 172, № 6. – P. 1573–1580.319.Lin, P. L. Understanding latent tuberculosis: a moving target / P. L. Lin, J.L. Flynn // J. Immunol. – 2010. – Vol. 185, № 1. – P. 15–22.320.Lipidated promiscuous peptides vaccine for tuberculosis-endemic regions /U. Gowthaman [et al.] // Trends Mol. Med. – 2012. – Vol. 18, № 10. – P.
607–614.238321.Liu, C. H. Innate immunity in tuberculosis: host defense vs pathogenevasion / C. H. Liu, H. Liu, B. Ge // Cell Mol. Immunol. – 2017. – Vol. 14, №12. – P. 963-975.322.Lobue, P. Treatment of latent tuberculosis infection: an update / P. Lobue,D. Menzies / Respirology. – 2010. – Vol. 15. – P. 603–622.323.Loss of RD1 contributed to the attenuation of the live tuberculosis vaccinesMycobacterium bovis BCG and Mycobacterium microti / A.
S. Pym [et al.] //Mol. Microbiol. – 2002. – Vol. 46, № 3. – P. 709–717.324.LTBI: latent tuberculosis infection or lasting immune responses to M.tuberculosis? A TBNET consensus statement / U. Mack [et al.] // Eur. Respir. J. –2009. – Vol. 33, № 5. – P. 956–973.325.Lyadova, I. V. Th1 and Th17 cells in tuberculosis: protection, pathology,and biomarkers. / I.
V. Lyadova, A. V. Panteleev // Mediators Inflamm. – 2015. –Р. 854507. – doi: 10.1155/2015/854507.326.Maartens, G. Tuberculosis / G. Maartens, R. J. Wilkinson // Lancet. – 2007.– Vol. 370, № 9604. – P. 2030–2043.327.Mackay, C. R. Chemokine receptors and T cell chemotaxis / C. R. Mackay// J. Exp. Med. – 1996. – Vol. 184. – P. 799–802.328.Macrophage immunoregulatory pathways in tuberculosis / M.
V. S.Rajaram [et al.] // Sem. Immunol. – 2014. – Vol. 26, № 6. – P. 471-485.329.Macrophages exposed to Mycobacterium tuberculosis release chemokinesable to recruit selected leucocyte subpopulations: focus on gamma delta cells / E.Ferrero [et al.] // Immunology. – 2003. – Vol. 108. № 3. – P. 365-374.330.Madariaga, M. G. Clinical utility of interferon gamma assay in thediagnosis of tuberculosis / M.
G. Madariaga, Z. Jalali, S. Swindells // J. Am.Board Family Med. – 2007. – Vol. 20, № 6. – P. 540–547.331.Mansbach, A. L. Control of recurrent ENT infections in children / A. L.Mansbach // Rev. Med. Brux. – 1994. – Vol. 15, № 4. – P. 198-201.239332.Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosiscomplex / C. Aagaard [et al.] // J. Infect. Dis. – 2004. – Vol.
189. – P. 812–819.333.Marcos, A. Changes in the immune system are conditioned by nutrition / A.Marcos, E. Nova, A. Montero // Eur. J. Clin. Nutr. – 2003. – Vol. 57, suppl. 1. –P. S66–S69.334.Maternal cocaine administration in mice alters DNA methylation and geneexpression in hippocampal neurons of neonatal and prepubertal offspring / S. I.Novikova [et al.] // PLoS ONE.
– 2008. – Vol. 3, № 4. – e1919.335.McClean, C. M. Macrophages form, function and phenotype inmycobacterial infection: lessons from tuberculosis and other diseases / C. M.McClean, D. M. Tobin // Pathog. Dis. – 2016. – Vol. 74. – Р. 1–15. – doi:10.1093/femspd/ftw068.336.Mechanisms of control of Mycobacterium tuberculosis by NK cells: role ofglutathione / M. Allen [et al.] // Front Immunol. – 2015. – Vol. 6. – Р. 508. – doi:10.3389/fimmu.2015.00508.337.Medzhitov, R. Recognition of microorganisms and activation of theimmune response / R.
Medzhitov // Nature. – 2007. – Vol. 449. – Р. 819–26. –doi: 10.1038/nature06246.338.Menzies, D. Meta-analysis: new tests for the diagnosis of latenttuberculosis infection: areas of uncertainty and recommendations for research / D.Menzies, M. Pai, G. Comstock // Ann. Intern. Med. – 2007. – Vol.
146. – P. 340–354.339.Mice that overexpress CC chemokine ligand 2 in their lungs showincreased protective immunity to infection with Mycobacterium bovis bacilleCalmette-Guérin / O. Schreiber [et al.] // J. Infect. Dis. – 2008. – Vol. 198, № 7.– P. 1044-1054.340.Molecular analysis of genetic differences between Mycobacterium bovisBCG and virulent M. bovis / G. G. Mahairas [et al.] // J. Bacteriol.
– 1996. – Vo.178, № 5. –- P. 1274–1282.240341.Moser, M. Dendritic cell regulation of TH1-TH2 development / M. Moser,K. M. Murphy // Nat. Immunol. – 2000. – № 1. – P. 199–205.342.Multifunctional CD4(+) T cells correlate with active Mycobacteriumtuberculosis infection / N. Caccamo [et al.] // Eur. J. Immunol. – 2010. – Vol. 40,№ 8. – P. 2211–2220.343.Multifunctional TH1 cells define a correlate of vaccine-mediated protectionagainst Leishmania major / P. A.
Darrah [et al.] // Nat. Med. – 2007. – Vol. 13. –P. 843–850.344.Mustafa, A. S. Development of new vaccines and diagnostic reagentsagainst tuberculosis / A. S. Mustafa // Mol. Immunol. – 2002. – Vol. 39. – P.113–119.345.Mustafa, A. S. Identification of Mycobacterium tuberculosis-specificgenomicregionsencoding antigens inducingprotectivecellularimmuneresponses / A. S. Mustafa, R. Al-Attiyah // Indian J.
Exp. Biol. – 2009. – Vol.47, № 6. – P. 498-504.346.Mustafa,A.S.Insilicoanalysisandexperimentalvalidationof Mycobacterium tuberculosis -specific proteins and peptides of Mycobacteriumtuberculosis for immunological diagnosis and vaccine development / A. S.Mustafa // Med. Princ. Pract. – 2013. – Vol.
22, suppl. 1. – P. 43-51.347.Mustafa, A. S. ProPred analysis and experimental evaluation ofpromiscuous T-cell epitopes of three major secreted antigens of Mycobacteriumtuberculosis / A. S. Mustafa, F. A. Shaban // Tuberculosis. – 2006. – Vol. 86, №2. – P. 115.348.Mustafa, A. S.
Recombinant and synthetic peptides to identifyMycobacterium tuberculosis antigens and epitopes of diagnostic and vaccinerelevance / A. S. Mustafa // Tuberculosis. – 2005. – Vol. 85, № 5/6. – P. 367-376.349.Mycobacteria-derived biomarkers for tuberculosis diagnosis / M.Druszczynska [et al.] // Indian J. Med. Res – 2017. – Vol. 146. – P. 700-707.241350.Mycobacterial antigen 85 complex (Ag85) as a target for ficolins andmannose-binding lectin / A. S.
Świerzko [et al.] // Int. J. Med. Microbiol. – 2016.– Vol. 306. – Р. 212-21.351.Mycobacterium bovis bacillus Calmette-Guerin secreting active cathepsin Sstimulates expression of mature MHC class II molecules and antigen presentationin human macrophages / H. Soualhine [et al.] // J. Immunol.
– 2007. – Vol. 179. –P. 5137–5145.352.Mycobacterium bovis BCG disrupts the interaction of Rab7 with RILPcontributing to inhibition of phagosome maturation / J. Sun [et al.] // J. Leukoc.Biol. – 2007. – Vol. 82. – P. 1437-1445.353.Mycobacterium tuberculosis gene expression profiling within the contextof protein networks / H. Rachman [et al.] // Microbes Infect. – 2006. – Vol. 8. –P.
747-757.354.Mycobacterium tuberculosis induces high production of nitric oxide incoordination with production of tumour necrosis factor-alpha in patients withfresh active tuberculosis but not in MDR tuberculosis / S. Sharma [et al.] //Immunol. Cell Biol. – 2004. – Vol. 82. – P. 377–382.355.Mycobacterium tuberculosis latent antigen rv2029c from the multistageDNA vaccine A39 drives th1 responses via TLR-mediated macrophage activation[Electronic resource] / H. Su [et al.] // Front.
Microbiol. – 2017. – Vol. 8. – DOI:10.3389/fmicb.2017.02266.356.Mycobacterium tuberculosis operon encoding ESAT6 and a novel low-molecular-mass culture filtrate protein (CFP-10) / F. X. Berthet [et al.] //Microbiology. – 1998. – Vol. 144. – P. 3195-203.357.Mycobacterium tuberculosis promotes apoptosis in human neutrophils byactivating caspase-3 and altering expression of Bax/Bcl-xL via an oxygendependent pathway / N. Perskvist [et al.] // J. Immunol. – 2002. – Vol. 168, № 12.– Р. 6358–65.
– doi: 10.4049/jimmunol.168.12.6358.242358.Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, inducesmaturation of dendritic cells and drives Th1 immune response / E.-H. Byun [etal.] // FASEB J. – 2012. – Vol. 26, № 6. – P. 2695–2711.359.Neopterin as an index of immune response in patients with tuberculosis / D.Fuchs [et al.] // Lung. – 1984. – Vol. 162. – P. 337–46.360.Novel and improved technologies for tuberculosis diagnosis: progress andchallenges / M.
Pai [et al.] // Clin. Chest. Med. – 2009. – Vol. 30, № 4. – P. 701–716.361.Okada, M. Frontier of mycobacterium research--host vs. mycobacterium /M. Okada, T. Shirakawa // Kekkaku. – 2005. – Vol. 80, № 9. – P. 613-629.362.Oliver, J. D. The viable but nonculturable state in bacteria / J. D. Oliver //J. Microbiol. – 2005. – Vol. 43. – P. 93-100.363.Ottenhoff, T. H.
Vaccines against tuberculosis: where are we and where dowe need to go? / T. H. Ottenhoff, S. H. Kaufmann // PLoS Pathog. 2012. – Vol. 8.– e1002607.364.Outdoor air pollution and acute respiratory infections among children indeveloping countries / I. Romieu [et al.] // J. Occup. Environ. Med.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
